Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Foeldvari

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
Journal of Scleroderma and Related Disorders|June 8, 2026
Are we ready to predict progressive disease in juvenile systemic sclerosis?Ivan Foeldvari, Jens Klotsche, Kathryn S Torok
Die Ophthalmologie|March 24, 2026
[Noninfectious uveitis in childhood : Clinical aspects, diagnostics, treatment and transition]Uwe Pleyer, Lynn Zur Bonsen, Ivan Foeldvari
Pediatric Rheumatology Online Journal|January 28, 2014
Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritisIvan Foeldvari, Nikolay Tzaribachev, Randy Q Cron
Pediatric Rheumatology Online Journal|July 13, 2019
Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?Greta Mastrangelo, Ivan Foeldvari, Jordi Anton, et al.
Zeitschrift Fur Rheumatologie|December 15, 2022
[Validation of the total morbidity score and investigation of the efficacy of methotrexate in localized scleroderma]Ann-Kathrin Hoppe, Suzanne C Li, Ivan Foeldvari
The Journal of Rheumatology|May 8, 2003
Juvenile spondyloarthritis and severe cardiac involvement in a female patientIvan Foeldvari, Christian Thiel, Michele Eiselt, et al.
Rheumatology International|November 1, 2019
Validation and adaptation of a German screening tool to identify patients at risk of juvenile idiopathic arthritisTristan Scheer, Jens Klotsche, Claudio A Len, et al.
The Journal of Rheumatology|May 23, 2002
High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritisIvan Foeldvari, Ruben Burgos-Vargas, Angelika Thon, et al.
Clinical Reviews in Allergy & Immunology|September 14, 2011
Cutting-edge issues in autoimmune uveitisRoger A Levy, Francisco Assis de Andrade, Ivan Foeldvari
The Journal of Rheumatology|March 15, 2026
Clinical Correlates of a successful transition in Pediatric RheumatologyHanna Maria Narberhaus, Stefanie Tatsis, Jens Klotsche, et al.
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Journal of Scleroderma and Related Disorders|June 8, 2026
Are we ready to predict progressive disease in juvenile systemic sclerosis?Ivan Foeldvari, Jens Klotsche, Kathryn S Torok
Die Ophthalmologie|March 24, 2026
[Noninfectious uveitis in childhood : Clinical aspects, diagnostics, treatment and transition]Uwe Pleyer, Lynn Zur Bonsen, Ivan Foeldvari
Pediatric Rheumatology Online Journal|January 28, 2014
Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritisIvan Foeldvari, Nikolay Tzaribachev, Randy Q Cron
Pediatric Rheumatology Online Journal|July 13, 2019
Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?Greta Mastrangelo, Ivan Foeldvari, Jordi Anton, et al.
Zeitschrift Fur Rheumatologie|December 15, 2022
[Validation of the total morbidity score and investigation of the efficacy of methotrexate in localized scleroderma]Ann-Kathrin Hoppe, Suzanne C Li, Ivan Foeldvari
The Journal of Rheumatology|May 8, 2003
Juvenile spondyloarthritis and severe cardiac involvement in a female patientIvan Foeldvari, Christian Thiel, Michele Eiselt, et al.
Rheumatology International|November 1, 2019
Validation and adaptation of a German screening tool to identify patients at risk of juvenile idiopathic arthritisTristan Scheer, Jens Klotsche, Claudio A Len, et al.
The Journal of Rheumatology|May 23, 2002
High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritisIvan Foeldvari, Ruben Burgos-Vargas, Angelika Thon, et al.
Clinical Reviews in Allergy & Immunology|September 14, 2011
Cutting-edge issues in autoimmune uveitisRoger A Levy, Francisco Assis de Andrade, Ivan Foeldvari
The Journal of Rheumatology|March 15, 2026
Clinical Correlates of a successful transition in Pediatric RheumatologyHanna Maria Narberhaus, Stefanie Tatsis, Jens Klotsche, et al.
Pageof 18